Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Cell Biology|May 12, 2015
Hitting cancers' weak spots: vulnerabilities imposed by p53 mutationEvrim Gurpinar, Karen H Vousden
Frontiers in Oncology|July 23, 2013
COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory DrugsEvrim Gurpinar, William E Grizzle, Gary A Piazza
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2013
NSAIDs inhibit tumorigenesis, but how?Evrim Gurpinar, William E Grizzle, Gary A Piazza
BMJ (Clinical Research Ed.)|October 6, 2017
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13Courtney Davis, Huseyin Naci, Evrim Gurpinar, et al.
Molecular Cancer Therapeutics|February 28, 2013
A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyEvrim Gurpinar, William E Grizzle, John J Shacka, et al.
Biomedical Chromatography : BMC|September 17, 2010
Development and validation of an HPLC method for quantitation of BA-TPQ, a novel iminoquinone anticancer agent, and an initial pharmacokinetic study in miceHaibo Li, Scharri J Ezell, Xiangrong Zhang, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Marine Drugs|August 18, 2010
Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agentScharri J Ezell, Haibo Li, Hongxia Xu, et al.
Molecular Cancer Therapeutics|June 28, 2013
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signalingNan Li, Yaguang Xi, Heather N Tinsley, et al.
Oncotarget|October 21, 2017
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signalingBing Zhu, Ashley Lindsey, Nan Li, et al.
Pageof 1